Irinotecan topoisomerase 1 inhibitor
WebIrinotecan (CPT-11, (+)-Irinotecan) is a topoisomerase I inhibitor for LoVo cells and HT-29 cells with IC50 of 15.8 μM and 5.17 μM, respectively. Features Irinotecan is a prodrug that … WebTopoisomerase I Inhibitors Name Topoisomerase I Inhibitors Accession Number DBCAT001116 Description Compounds that inhibit the activity of DNA TOPOISOMERASE I. Drugs Drugs & Drug Targets
Irinotecan topoisomerase 1 inhibitor
Did you know?
WebIrinotecan (CPT-11), a prodrug for treating metastatic colorectal cancer, is a topoisomerase I inhibitor for LoVo cells and HT-29 cells with IC50 of 15.8 μM and 5.17 μM, respectively … WebDec 1, 1997 · Irinotecan (CPT-11), a semi-synthetic derivative of camptothecin, is approved in the United States for the treatment of colorectal cancer. Ongoing clinical trials with CPT-11 show a 13% to 32% response rate when it is used singly or in combination with other chemotherapeutic agents such as 5-fluorouracil.
WebDec 1, 1997 · Abstract. Topoisomerase I inhibitors are a new class of anticancer agents with a mechanism of action aimed at interrupting DNA replication in cancer cells, the result of … WebFeb 16, 2024 · Irinotecan liposome injection is a topoisomerase 1 inhibitor encapsulated in a lipid bilayer vesicle or liposome. Topoisomerase 1 relieves torsionalstrain in DNA by inducing single-strand breaks. …
WebMar 21, 2024 · Irinotecan, a prodrug of 7-ethyl 10-hydroxycamptothecin (SN38), is an antineoplastic agent of the topoisomerase (Top1) inhibitor class that is widely used to treat colorectal and other gastrointestinal cancers. The pharmacokinetics and metabolism of irinotecan and SN38 in humans are well described in the literature [ 1, 2, 3, 4, 5 ]. WebThe anticancer agent, irinotecan, is a prodrug that is converted by tissue carboxylesterase to 7-ethyl-10-hydroxycamptothecin (SN-38), a potent inhibitor of DNA topoisomerase I. Its action is terminated by glucuronidation by UDP glucuronosyl transferase. Safety Information Pictograms GHS07 Signal Word Warning Hazard Statements H302
WebNov 22, 2011 · The topoisomerase I (Top 1) poison irinotecan is an important component of the modern treatment of colorectal cancer. By stabilising Top 1-DNA complexes, … thunder bay behavioral healthWebIrinotecan (CPT-11, (+)-Irinotecan) is a topoisomerase I inhibitor for LoVo cells and HT-29 cells with IC50 of 15.8 μM and 5.17 μM, respectively. Camptothecin (NSC-100880) Camptothecin (NSC-100880, CPT, Campathecin, (S)- (+)-Camptothecin) is a specific inhibitor of DNA topoisomerase I (Topo I) with IC50 of 0.68 μM in a cell-free assay. thunder bay bike storeWebIrinotecan is an antineoplastic enzyme inhibitor primarily used in the treatment of colorectal cancer. It is a derivative of camptothecin that inhibits the action of topoisomerase I. … thunder bay bgcWebFeb 13, 2024 · Irinotecan (SN-38) is a potent and broad-spectrum anticancer drug that targets DNA topoisomerase I (Top1). It exerts its cytotoxic effects by binding to the Top1 … thunder bay bell canadaWebNov 4, 2024 · Irinotecan is a topoisomerase I inhibitor used to treat several solid tumor types, especially in combination with other chemotherapeutic agents in the treatment of colorectal cancer. Irinotecan combined with 5-fluorouracil (5FU) is widely used in the treatment of colorectal cancer. [ 1] Inhibition of topoisomerase I by irinotecan and its … thunder bay bikeWebIrinotecan ( (+)-Irinotecan) is a topoisomerase I inhibitor, preventing religation of the DNA strand by binding to topoisomerase I-DNA complex. For research use only. We do not sell … thunder bay biaWebMay 27, 2015 · Irinotecan (brand name Camptosar) is a topoisomerase I inhibitor widely used in the treatment of cancer. It is most frequently used in combination with other drugs to treat advanced or metastatic colorectal cancer. However, irinotecan therapy is associated with a high incidence of toxicity, including severe neutropenia and diarrhea (1). thunder bay bids and tenders